Constipation in neurological diseases

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 1, 2003, Pages 13-19

  Winge, K ^a   Rasmussen, D ^a   Werdelin, L M ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACEGLUTAMIDE ALUMINUM; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; BISACODYL; BULKING AGENT; CALCIUM CARBONATE; CASTOR OIL; CHOLINERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; DOCUSATE SODIUM; FLEET ENEMA; GANGLION BLOCKING AGENT; LACTULOSE; LAXATIVE; LEVODOPA; MAGNESIUM SALT; NEUROLEPTIC AGENT; OSMOTIC AGENT;

ACCURACY; ACUTE INTERMITTENT PORPHYRIA; ANORECTAL PRESSURE; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; BACTERIAL OVERGROWTH; BARIUM ENEMA; BLADDER DYSFUNCTION; COLON MOTILITY; CONSTIPATION; DEFECATION DISORDER; DIETARY INTAKE; DISEASE ASSOCIATION; FAMILIAL AMYLOID POLYNEUROPATHY; FECES INCONTINENCE; HUMAN; HYPERGLYCEMIA; HYPOVOLEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE TRANSIT TIME; MULTIPLE SCLEROSIS; NERVE TRANSECTION; NEUROLOGIC DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PARASYMPATHETIC INNERVATION; PARESIS; PARKINSONISM; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; SHY DRAGER SYNDROME; SPEECH DISORDER; SPINE INJURY; STROKE; SUPPOSITORY; SYMPATHETIC INNERVATION; TREATMENT PLANNING; VAGUS NERVE;

AUTONOMIC NERVOUS SYSTEM DISEASES; CEREBROVASCULAR ACCIDENT; CONSTIPATION; HUMANS; MULTIPLE SCLEROSIS; MULTIPLE SYSTEM ATROPHY; NERVOUS SYSTEM DISEASES; PARKINSONIAN DISORDERS; SPINAL CORD DISEASES;

EID: 0037229212     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.1.13     Document Type: Review

References (77)

1. Johanson JF, Sonnenberg A, Koch TR, et al. Association of constipation with neurologic diseases. Dig Dis Sci 1992;37:179-86.
2. Cooke H J. Neurobiology of the intestinal mucosa. Gastroenterology 1986;90:1057-81.
3. Longo WE, Ballantyne GH, Modlin IM. The colon, anorectum, and spinal cord patient. A review of the functional alterations of the denervated hindgut. Dis Colon Rectum 1989;32:261-7.
4. Craggs MD, Vaizey CJ. Neurophysiology of the bladder and bowel. In: Fowler CJ, ed. Neurology of Bladder, Bowel and Sexual Dysfunction. Boston: Butterworth Heinemann, 1999.
5. Glickman S, Kamm MA. Bowel dysfunction in spinal-cord-injury patients. Lancet 1996;347:1651-3.
6. Ashraf W, Park F, Lof J, et al. An examination of the reliability of reported stool frequency in the diagnosis of idiopathic constipation. Am J Gastroenterol 1996;91:26-32.
7. Agachan F, Chen T, Pfeifer J, et al. A constipation scoring system to simplify evaluation and management of constipated patients. Dis Colon Rectum 1996;39:681-5.
8. Weber J, Grise P, Roquebert M, et al. Radiopaque markers transit and anorectal manometry in 16 patients with multiple sclerosis and urinary bladder dysfunction. Dis Colon Rectum 1987;30:95-100.
9. Bouchoucha M, Thomas SR. Error analysis of classic colonic transit time estimates. Am J Physiol Gastrointest Liver Physiol 2000;279:G520-7.
10. Prokesch RW, Breitenseher MJ, Kettenbach J, et al. Assessment of chronic constipation: Colon transit time versus defecography. Eur J Radiol 1999;32:197-203.
11. Stocchi F. Disorders of bowel function in parkinsonism. In: Fowler CJ, ed. Neurology of bladder, bowel, and sexual dysfunction. Boston: Butterworth Heinemann, 1999.
12. Stewart WF, Liberman JN, Sandler RS, et al. Epidemiology of constipation (EPOC) study in the United States: Relation of clinical subtypes to sociodemographic features. Am J Gastroenterol 1999;94:3530-40.
13. Chiarelli P, Brown W, McElduff P. Constipation in Australian women: Prevalence and associated factors. Int Urogynecol J Pelvic Floor Dysfunct 2000;11:71-8.
14. Liu F, Kondo T, Toda Y. Brief physical inactivity prolongs colonic transit time in elderly active men. Int J Sports Med 1993;14:465-7.
15. Meshkinpour H, Selod S, Movahedi H, et al. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci 1998;43:2379-83.
16. Robertson G, Meshkinpour H, Vandenberg K, et al. Effects of exercise on total and segmental colon transit. J Clin Gastroenterol 1993;16:300-3.
17. Donald I P, Smith RG, Cruikshank JG, et al. A study of constipation in the elderly living at home. Gerontology 1985;31:112-18.
18. Ullman T, Reding M. Gastrointestinal dysfunction in stroke. Semin Neurol 1996;16:269-75.
19. Bassotti G, De Giorgio R, Stanghellini V, et al. Constipation: A common problem in patients with neurological abnormalities [published erratum appears in Ital J Gasroenterol Hepatol 1999;31:following 248]. Ital J Gastroenterol Hepatol 1998;30:542-8.
20. Parkinson J. An Essay on Shaking Palsy. London: Whittingham and Rowland, 1817.
21. Sakakibara R, Shinotoh H, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in Parkinson's disease. Auton Neurosci 2001;92:76-85.
22. Edwards LL, Quigley EM, Harned RK, et al. Characterization of swallowing and defecation in Parkinson's disease. Am J Gastroenterol 1994;89:15-25.
23. Jost WH, Schimrigk K. Constipation in Parkinson's disease. Klin Wochenschr 1991;69:906-9.
24. Jost WH. Gastrointestinal motility problems in patients with Parkinson's disease. Effects of antiparkinsonian treatment and guidelines for management. Drugs Aging 1997;10:249-58.
25. Edwards LL, Pfeiffer RF, Quigley EM, et al. Gastrointestinal symptoms in Parkinson's disease. Mov Disord 1991;6:151-6.
26. Qualman SJ, Haupt HM, Yang P, et al. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology 1984;87:848-56.
27. Singaram C, Ashraf W, Gaumnitz EA, et al. Dopaminergic defect of enteric nervous system in Parkinson's disease patients with chronic constipation. Lancet 1995;346:861-4.
28. Kupsky WJ, Grimes MM, Sweeting J, et al. Parkinson's disease and megacolon: Concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 1987;37:1253-5.
29. Ohama E, Ikuta F. Parkinson's disease: Distribution of Lewy bodies and monoamine neuron system. Acta Neuropathol(Berl) 1976;34:311-19.
30. Oyanagi K, Wakabayashi K, Ohama E, et al. Lewy bodies in the lower sacral parasympathetic neurons of a patient with Parkinson's disease. Acta Neuropathol(Berl) 1990;80:558-9.
31. Wakabayashi K, Takahashi H, Takeda S, et al. Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol (Berl) 1988;76:217-21.
32. Jost WH, Schrank B. Defecatory disorders in de novo Parkinsonians - Colonic transit and electromyogram of the external anal sphincter. Wien Klin Wochenschr 1998;110:535-7.
33. Korczyn AD. Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 1990;53:463-8.
34. Djaldetti R, Koren M, Ziv I, et al. Effect of cisapride on response fluctuations in Parkinson's disease. May Disord 1995;10:81-4.
35. Neira WD, Sanchez V, Mena MA, et al. The effects of cisapride on plasma L-dopa levels and clinical response in Parkinson's disease. Mov Disord 1995;10:66-70.
36. Levein NG, Thorn SE, Wattwil M. Dopamine delays gastric emptying and prolongs orocaecal transit time in volunteers. Eur J Anaesthesiol 1999;16:246-50.
37. Bassotti G, Maggio D, Battaglia E, et al. Manometric investigation of anorectal function in early and late stage Parkinson's disease. J Neurol Neurosurg Psychiatry 2000;68:768-70.
38. Stocchi F, Badiali D, Vacca L, et al. Anorectal function in multiple system atrophy and Parkinson's disease. May Disord 2000;15:71-6.
39. Niimi Y, Ieda T, Hirayama M, et al. Clinical and physiological characteristics of autonomic failure with Parkinson's disease. Clin Auton Res 1999;9:139-44.
40. Tison F, Arne P, Sourgen C, et al. The value of external anal sphincter electromyography for the diagnosis of multiple system atrophy. Mov Disord. 2000;15:1148-57.
41. Bakke A, Myhr KM, Gronning M, et al. Bladder, bowel and sexual dysfunction in patients with multiple sclerosis-a cohort study. Scand J Urol Nephrol Suppl 1996;179:61-6.
42. Hennessey A, Robertson NP, Swingler R, et al. Urinary, faecal and sexual dysfunction in patients with multiple sclerosis. JNeurol 1999;246:1027-32.
43. Chia YW, Fowler CJ, Kamm MA, et al. Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. J Neurol 1995;242:105-8.
44. Fowler CJ, van Kerrebroeck PE, Nordenbo A, et al. Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis). J Neurol Neurosurg Psychiatry 1992;55:986-9.
45. Fowler CJ. The cause and management of bladder, sexual and bowel symptoms in multiple sclerosis. Baillieres Clin Neurol 1997;6:447-66.
46. Nordenbo AM, Andersen JR, Andersen JT. Disturbances of ano-rectal function in multiple sclerosis. J Neurol 1996;243:445-51.
47. Gill KP, Chia YW, Henry MM., Shorvon PJ. Defecography in multiple sclerosis patients with severe constipation. Radiology 1994;191:553-6.
48. Binnie NR, Smith AN, Creasey GH, et al. Constipation associated with chronic spinal cord injury: The effect of pelvic parasympathetic stimulation by the Brindley stimulator. Paraplegia 1991;29:463-9.
49. Menardo G, Bausano G, Corazziari E, et al. Large-bowel transit in paraplegic patients. Dis Colon Rectum 1987;30:924-8.
50. Stone JM, Nino-Murcia M, Wolfe VA, et al. Chronic gastrointestinal problems in spinal cord injury patients: A prospective analysis. Am J Gastroenterol 1990;85:1114-19.
51. Hussain IF. Cauda equina damage and its management In: Fowler CJ, ed. Neurology of Bladder, Bowel, and Sexual Dysfunction. Boston: Butterworth Heinemann, 1999.
52. Geders JM, Gaing A, Bauman WA, et al. The effect of cisapride on segmental colonic transit time in patients with spinal cord injury. Am J Gastroenterol 1995;90:285-9.
53. Perkin GD, Murray-Lyon I. Neurology and the gastrointestinal system. J Neural Neurosurg Psychiatry 1998;65:291-300.
54. Enck P, Rathmann W, Spiekermann M, et al. A. Prevalence of gastrointestinal symptoms in diabetic patients and non- diabetic subjects. Z Gastroenterol 1994;32:637-41.
55. Maleki D, Locke GR III, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000;160:2808-16.
56. Chelimsky G, Wszolek Z, Chelimsky TC. Gastrointestinal dysfunction in autonomic neuropathy. Semin Neural 1996;16:259-68.
57. Camilleri M, Bharucha AE. Gastrointestinal dysfunction in neurologic disease. Semin Neurol 1996;16:203-16.
58. Veilleux M, Bernier JP, Lamarche JB. Paraneopiastic encephalomyelitis and subacute dysautonomia due to an occult atypical carcinoid tumour of the lung. Can J Neurol Sci 1990;17:324-8.
59. Colombel JF, Parent M, Lescut D, et al. Paraneoplastic intestinal pseudo-obstruction as the presenting feature of small-cell lung cancer. Gastroenterol Clin Biol 1988;12:394-6.
60. Fuger K, Barnert J, Hopfner W, et al. Intestinal pseudoobstruction as a feature of myotonic muscular dystrophy. Z Gastroenterol 1995;33:534-8.
61. Lenard HG, Goebel HH, Weigel W. Smooth muscle involvement in congenital myotonic dystrophy. Neuropadiatrie 1977;8:42-52.
62. Norris FH, Smith RA, Denys EH. The treatment of amyotrophic lateral sclerosis. Adv Exp Med Biol 1987;209:175-82.
63. Bergmann M, Volpel M, Kuchelmeister K. Onuf's nucleus is frequently involved in motor neuron disease/amyotrophic lateral sclerosis. J Neurol Sci 1995;129:141-6.
64. Carvalho M, Schwartz MS, Swash M. Involvement of the external anal sphincter in amyotrophic lateral sclerosis. Muscle Nerve 1995; 18:848-53.
65. Knowles CH, Scott SM, Lunniss PJ. Slow transit constipation: A disorder of pelvic autonomic nerves? Dig Dis Sci 2001;46:389-401.
66. Norton C, Henry MM. Investigation and treatment of bowel problems. In: Fowler CJ, ed. Neurology of Bladder, Bowel and Sexual Dysfunction. Boston: Butterworth Heinemann, 1999.
67. Petticrew M, Watt I, Brand M. What's the 'best buy' for treatment of constipation? Results of a systematic review of the efficacy and comparative efficacy of laxatives in the elderly. Br J Gen Pract 1999;49:387-93.
68. Wiesel PH, Norton C, Brazzelli M. Management of faecal incontinence and constipation in adults with central neurological diseases. The Cochrane Library 2000.
69. Passmore AP, Wilson-Davies K, Stoker C, et al. Chronic constipation in long stay elderly patients: A comparison of lactulose and a senna-fibre combination. BMJ 1993;307:769-71.
70. Sheehy C, Hall GR. Rethinking the obvious. A model for preventing constipation. J Gerontol Nurs 1998;24:38-44.
71. Koutsomanis D, Lennard-Jones JE, Roy AJ, et al. Controlled randomised trial of visual biofeedback versus muscle training without a visual display for intractable constipation. Gut 1995;37:95-9.
72. Wiesel PH, Norton C, Roy AJ, et al. Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis. J Neurol Neurosurg Psychiatry 2000;69:240-3.
73. Stark ME. Challenging problems presenting as constipation. Am J Gastroenterol 1999;94:567-74.
74. Jost WH, Schimrigk K. Cisapride treatment of constipation in Parkinson's disease. Mov Disord 1993;8:339-43.
75. Jost WH, Schimrigk K. The effect of cisapride on delayed colonic transit time in patients with idiopathic Parkinson's disease. Wien Klin Wochenschr 1994;106:673-6.
76. Jost WH, Schimrigk K. Long-term results with cisapride in Parkinson's disease. Mov Disord 1997;12:423-5.
77. Ashraf W, Pfeiffer RF, Park F, et al. Constipation in Parkinson's disease: Objective assessment and response to psyllium. Mov Disord 1997;12:946-51.